Shell Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Sell |
|
|||||
|
2025
Q1 | $437K | Sell |
|
|||||
|
2024
Q4 | $429K | Hold |
|
|||||
|
2024
Q3 | $394K | Buy |
|
|||||
|
2024
Q1 | $292K | Sell |
|
|||||
|
2023
Q4 | $322K | Sell |
|
|||||
|
2023
Q3 | $351K | Sell |
|
|||||
|
2023
Q2 | $291K | Sell |
|
|||||
|
2023
Q1 | $386K | Sell |
|
|||||
|
2022
Q4 | $364K | Sell |
|
|||||
|
2022
Q3 | $555K | Sell |
|
|||||
|
2022
Q2 | $649K | Buy |
|
|||||
|
2022
Q1 | $614K | Sell |
|
|||||
|
2021
Q4 | $619K | Buy |
|
|||||
|
2021
Q3 | $613K | Sell |
|
|||||
|
2021
Q2 | $714K | Buy |
|
|||||
|
2021
Q1 | $580K | Sell |
|
|||||
|
2020
Q4 | $641K | Hold |
|
|||||
|
2020
Q3 | $427K | Hold |
|
|||||
|
2020
Q2 | $412K | Buy |
|